康德莱收盘上涨2.46%，滚动市盈率15.18倍，总市值32.72亿元

Group 1 - The core viewpoint of the article highlights the performance and valuation of Kangdelai, a company in the medical device industry, which has a current PE ratio of 15.18, significantly lower than the industry average of 49.64 [1][2] - As of March 31, 2025, Kangdelai has 25,817 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, production, sales, and service of medical devices, including various types of medical needles and infusion devices [1] Group 2 - In the latest quarterly report for Q1 2025, Kangdelai reported a revenue of 548 million yuan, a year-on-year decrease of 3.82%, and a net profit of 60.70 million yuan, with a slight increase of 0.28% [1] - The gross profit margin for the company stands at 32.02% [1] - Kangdelai ranks 35th in terms of PE ratio within its industry, which has a median PE of 36.36 [2]